Breakingviews - Gilead gives glimpse into feverish drug market - Reuters

1:23pm PDT - June 29th, 2020    remdesivir - Reuters

(Reuters Breakingviews) - Medicine may be a science but drug pricing is definitely an art. That’s especially true of Gilead Sciences’ treatment for Covid-19, given the lack of alternative treatments for a pandemic. The $2,300 price of a course of remdesivir m…